Recruitment in AIDS clinical trials: Investigation of sociodemographic and psychosocial factors affecting participation in clinical research

AIDS and Behavior

Volumn 3, Issue 3, 1999, Pages 219-230

  Ethier, Kathleen A ^a,b   Rodriguez, Michael R ^b   Fox Tierney, Rachel A ^a   Martin, Chloe ^b   Friedland, Gerald ^a   Ickovics, Jeannette R ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

AIDS clinical trials; Attitudes; Injection drug users; Minorities; Psychosocial; Recruitment; Underrepresented populations; Women

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; ATTITUDE; CLINICAL RESEARCH; DEMOGRAPHY; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; SOCIAL BEHAVIOR; SOCIAL PSYCHOLOGY;

EID: 0032723518     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025456527845     Document Type: Article

References (21)

1. Altice, F. L., Mostashari, F., Thompson, A. S., and Friedland, G. (1997). Perceptions, acceptance and adherence to antiretrovirals among prisoners. Presented at the 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC.
2. Blaschke, T. F. (1997). Noncompliance and resistance to protease inhibitors. Presented at the 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC.
3. Centers for Disease Control and Prevention (1996). HIV/AIDS Surveillance Report [through June 1996], Atlanta, GA: Author.
4. Cotton, D., Finkelstein, D., He, W., and Feinberg, J. (1993). Determinants of accrual of women to a large, multicenter clinical trials program of human immunodeficiency virus infection. Journal of Acquired Immune Deficiency Syndrome, 6, 1322-1328.
5. Craven, D. E., Liebman, H. A., and Fuller, J. (1990). AIDS in intravenous drug users: Issues related to enrollment in clinical trials. Journal of Acquired Immune Deficiency Syndrome, 3, S45-S50.
6. El-Sadr, W., and Capps, L. (1992). The challenge of minority recruitment in clinical trials. Journal of the American Medical Association, 267, 954-957.
7. Ethier, K. A., Ickovics, J. R., and Rodin, J. (1996). For whose benefit? Women, and AIDS public policy. In A. O'Leary and L. S. Jemmott (Eds.), Women and AIDS: Coping and Care (pp. 207-228). New York: Plenum.
8. Grokin, L., Schron, E. B., Handshaw, K., Shea, S., Kinney, M. R., Branyon, M., Campion, J., Bigger, J. T., Jr., Sylvia, S. C., Duggan, J., Stylianou, M., Lancaster, S., Ahern, D. K., and Follick, M. J. (1996). Clinical trial enrollers vs. nonenrollers: The Cardiac Arrythmia Suppression Trial (CAST) Recruitment and Enrollment Assessment in Clinical Trials (REACT) project. Controlled Clinical Trials, 17, 46-59.
9. Haynes, R. B., Taylor, D. W., and Sackett, D. L. (1979). Compliance in health care. Baltimore, MD: Johns Hopkins University Press.
10. Ickovics, J. R., and Meisler, A. W. (1997). Adherence in AIDS clinical trials: A framework for clinical research and clinical care. Journal of Clinical Epidemiology, 50, 385-391.
11. Ickovics, J. R., and Rodin, J. (1994). Women and AIDS in the United States: Epidemiology, natural history and mediating mechanisms. Health Psychology, 11, 1-16.
12. Ingelfinger, H. J., Harris, C. A., Chidekel, J., Fenn, M. A., Tirrito, G., McCabe, K. M., Widrow, C. A., Choi, Y. S., and Soeiro, R. (1994). Successful enrollment of members of a largely minority heterosexual intravenous drug using population: An analysis of obstacles and effort. Paper presented to the Under-Represented Populations Committee, ACTG Clinical Trials Meeting, Washington, DC.
13. MacQueen, K. M., Buchbinder, S., Douglas, J. M., Judson, F. N., McKirnan, D. J., and Bartholow, B. (1994). The decision to enroll in HIV vaccine efficacy trials: Concerns elicited from gay men at increased risk for HIV infection. AIDS Research and Human Retroviruses, 10, S261-S264.
14. Morse, E. V., Simon, P. M., Besch, C. L., and Walker, J. (1995). Issues of recruitment, retention, and compliance in community-based clinical trials with traditionally under-served populations. Applied Nursing Research, 8, 8-14.
15. National Institute of Allergies and Infectious Diseases, AIDS Clinical Trials Group. (1996). Annual Report. Rockville, MD: AIDS Information Service.
16. Roberson, N. L. (1996). Clinical trial participation: Viewpoints from racial/ethnic groups. Cancer, 74, S2687-S2691.
17. Robinson, D., Woerner, M. G., Pollack, S., and Lerner, G. (1996). Subject selection biases in clinical trials: Data from a multicenter schizophrenia treatment study. Journal of Clinical Psychopharmacology, 16, 170-176.
18. Ross, M. W., Jeffords, K., and Gold, J. (1993). Reasons for entry into and understanding of HIV/AIDS clinical trials: A preliminary study. AIDS Care, 6, 77-82.
19. Stone, V. E., Mauch, M. Y., Steger, K., Janas, S. F., and Craven, D. E. (1997). Race, sex, drug use and participation in AIDS clinical trials: Lessons from a municipal hospital cohort. Journal of General Internal Medicine, 12, 150-157.
20. Swanson, G. M., and Ward, A. J. (1995). Recruiting minorities into clinical trials: Toward a participant-friendly system. Journal of National Cancer Institute, 87, 1747-1759.
21. Wainberg, M. A., and Friedland, G. (1998). Public health implications of antiretroviral therapy and HIV drug resistance. Journal of the American Medical Association, 279, 1977-1983.